Free Trial

Scancell (SCLP) Competitors

Scancell logo
GBX 8.30 -0.45 (-5.14%)
As of 02/21/2025 11:46 AM Eastern

SCLP vs. HZD, VRP, FARN, ARIX, BVXP, AVCT, 4BB, CIR, HVO, and TILS

Should you be buying Scancell stock or one of its competitors? The main competitors of Scancell include Horizon Discovery Group plc (HZD.L) (HZD), Verona Pharma plc (VRP.L) (VRP), Faron Pharmaceuticals Oy (FARN), Arix Bioscience (ARIX), Bioventix (BVXP), Avacta Group (AVCT), 4basebio (4BB), Circassia Group (CIR), hVIVO (HVO), and Tiziana Life Sciences (TILS). These companies are all part of the "biotechnology" industry.

Scancell vs.

Horizon Discovery Group plc (HZD.L) (LON:HZD) and Scancell (LON:SCLP) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, valuation, earnings, institutional ownership, risk, analyst recommendations, profitability and community ranking.

46.5% of Scancell shares are owned by institutional investors. 5.0% of Scancell shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Scancell had 3 more articles in the media than Horizon Discovery Group plc (HZD.L). MarketBeat recorded 3 mentions for Scancell and 0 mentions for Horizon Discovery Group plc (HZD.L). Scancell's average media sentiment score of 0.26 beat Horizon Discovery Group plc (HZD.L)'s score of 0.00 indicating that Scancell is being referred to more favorably in the news media.

Company Overall Sentiment
Horizon Discovery Group plc (HZD.L) Neutral
Scancell Neutral

Scancell's return on equity of 98.74% beat Horizon Discovery Group plc (HZD.L)'s return on equity.

Company Net Margins Return on Equity Return on Assets
Horizon Discovery Group plc (HZD.L)N/A N/A N/A
Scancell N/A 98.74%-45.28%

Horizon Discovery Group plc (HZD.L) has higher revenue and earnings than Scancell. Scancell is trading at a lower price-to-earnings ratio than Horizon Discovery Group plc (HZD.L), indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Horizon Discovery Group plc (HZD.L)£54.63M0.00N/A-£5.50N/A
ScancellN/AN/A-£6.75M-£0.65-12.73

Horizon Discovery Group plc (HZD.L) received 274 more outperform votes than Scancell when rated by MarketBeat users. However, 74.50% of users gave Scancell an outperform vote while only 73.52% of users gave Horizon Discovery Group plc (HZD.L) an outperform vote.

CompanyUnderperformOutperform
Horizon Discovery Group plc (HZD.L)Outperform Votes
461
73.52%
Underperform Votes
166
26.48%
ScancellOutperform Votes
187
74.50%
Underperform Votes
64
25.50%

Summary

Scancell beats Horizon Discovery Group plc (HZD.L) on 8 of the 11 factors compared between the two stocks.

Get Scancell News Delivered to You Automatically

Sign up to receive the latest news and ratings for SCLP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SCLP vs. The Competition

MetricScancellBiotechnology IndustryMedical SectorLON Exchange
Market Cap£85.97M£117.95M£5.84B£2.64B
Dividend YieldN/A3.69%4.75%4.98%
P/E Ratio-12.733.2026.04162.45
Price / SalesN/A4,826.69447.46313,322.68
Price / Cash7.8613.0138.0128.12
Price / Book-21.2947.077.645.16
Net Income-£6.75M-£87.82M£3.18B£5.75B
7 Day Performance-6.15%0.34%-2.00%-0.99%
1 Month Performance-14.08%3.63%-0.44%-0.80%
1 Year Performance-22.97%99.15%16.44%39.55%

Scancell Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SCLP
Scancell
N/AGBX 8.30
-5.1%
N/A-26.2%£85.97MN/A-12.7351News Coverage
Gap Down
HZD
Horizon Discovery Group plc (HZD.L)
N/AN/AN/AN/A£302.98M£54.63M-33.55416
VRP
Verona Pharma plc (VRP.L)
N/AN/AN/AN/A£228MN/A-1.6822Gap Up
FARN
Faron Pharmaceuticals Oy
N/AGBX 168.50
+0.6%
N/A+32.3%£226.21MN/A-4.5134
ARIX
Arix Bioscience
N/AN/AN/AN/A£183.73M£14.16M1,290.919
BVXP
Bioventix
N/AGBX 2,900
-0.9%
N/A-41.7%£151.85M£13.65M18.7612Negative News
AVCT
Avacta Group
N/AGBX 39.37
-5.4%
N/A-53.9%£149.55M£26.29M-5.07120High Trading Volume
4BB
4basebio
N/AGBX 1,120
flat
N/A+52.3%£143.47M£311,000.00-1,435.90101
CIR
Circassia Group
N/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap Down
HVO
hVIVO
N/AGBX 18
+0.6%
N/A-29.0%£127.37M£68.74M7.42N/A
TILS
Tiziana Life Sciences
N/AN/AN/AN/A£113.85M£-3,595,000.00-3.5911News Coverage

Related Companies and Tools


This page (LON:SCLP) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners